Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
American Heart Journal.
Times cited: 63
The prevalence and outcome of excess body weight among middle eastern patients presenting with acute coronary syndrome.
Times cited: 10